









Markets
/
Stocks
/
nasdaq-mbx
/

MBX Biosciences Inc

MBX

10.070USD

+0.130+1.31%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

338.27MMarket Cap

LossP/E TTM



MBX Biosciences Inc

10.070

+0.130+1.31%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-31.38%-17.43M

-111.75%-22.68M

-43.88%-16.04M

-89.80%-14.66M

-79.79%-13.27M

-87.07%-10.71M

---11.15M

---7.73M

---7.38M

---5.72M

Net income from continuing operations

-22.41%-19.41M

-93.56%-23.88M

-76.25%-15.59M

-78.51%-18.14M

-108.43%-15.86M

-107.38%-12.34M

---8.84M

---10.16M

---7.61M

---5.95M

Operating gains losses

-3.17%61.00K

60.42%77.00K

41.46%58.00K

87.50%75.00K

61.54%63.00K

29.73%48.00K

--41.00K

--40.00K

--39.00K

--37.00K

Other non-cash items

-126.81%-939.00K

-174.90%-1.31M

-138.26%-1.37M

-6322.22%-560.00K

-197.84%-414.00K

-95.90%-478.00K

---575.00K

--9.00K

---139.00K

---244.00K

Change in working capital

-54.53%918.00K

38.25%600.00K

78.05%-627.00K

54.63%2.77M

1879.41%2.02M

91.19%434.00K

---2.86M

--1.79M

--102.00K

--227.00K

-Change in prepaid expenses

31.35%-795.00K

303.92%1.65M

22.16%-1.03M

-562.60%-569.00K

-687.76%-1.16M

36.45%408.00K

---1.32M

--123.00K

---147.00K

--299.00K

-Change in other current assets

---566.00K

----

--0.00

---8.00K

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-31.38%-17.43M

-111.75%-22.68M

-43.88%-16.04M

-89.80%-14.66M

-79.79%-13.27M

-87.07%-10.71M

---11.15M

---7.73M

---7.38M

---5.72M

Investing cash flow

Net cash from continuing investing activities

56.42%707.00K

-89.01%30.00K

67.27%92.00K

159.09%57.00K

1358.06%452.00K

1200.00%273.00K

--55.00K

--22.00K

--31.00K

--21.00K

Capital expenditures

56.42%707.00K

-89.01%30.00K

67.27%92.00K

159.09%57.00K

1358.06%452.00K

1200.00%273.00K

--55.00K

--22.00K

--31.00K

--21.00K

Net cash flow from disposal of fixed assets

56.42%707.00K

-89.01%30.00K

67.27%92.00K

159.09%57.00K

1358.06%452.00K

1200.00%273.00K

--55.00K

--22.00K

--31.00K

--21.00K

Net cash flow from investment products

458.83%26.69M

-79.26%3.26M

-132.71%-67.25M

-442.06%-100.73M

-137.19%-7.44M

573.67%15.70M

---28.90M

---18.58M

--20.00M

---3.31M

Cash from non-current investing activities

Net cash flow from investing activities

429.31%25.99M

-79.09%3.23M

-132.59%-67.34M

-441.73%-100.79M

-139.52%-7.89M

562.50%15.43M

---28.95M

---18.61M

--19.97M

---3.34M

Financing cash flow

Cash flow from continuous financing activities

175.30%1.33M

-97.81%4.00K

-794.74%-132.00K

244.27%235.81M

-377.76%-1.76M

165.22%183.00K

--19.00K

--68.50M

--634.00K

--69.00K

Net cash flow from debt Issuance/repayment

----

--0.00

----

Net cash flow from common stock issuance/repurchase

----

--0.00

--174.54M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-7.31%63.50M

----

--0.00

--68.51M

----

Proceeds from stock option exercised by employees

2552.00%1.33M

-97.88%4.00K

926.32%195.00K

-282.35%-31.00K

-92.11%50.00K

173.91%189.00K

--19.00K

--17.00K

--634.00K

--69.00K

Net cash flow from other financing activities

100.00%0.00

---327.00K

-7223.33%-2.20M

---1.81M

---6.00K

--0.00

---30.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

175.30%1.33M

-97.81%4.00K

-794.74%-132.00K

244.27%235.81M

-377.76%-1.76M

165.22%183.00K

--19.00K

--68.50M

--634.00K

--69.00K

Net cash flow

Beginning cash balance

-15.59%29.90M

61.68%49.35M

88.18%132.87M

-56.04%12.50M

132.78%35.42M

26.08%30.52M

--70.61M

--28.44M

--15.22M

--24.21M

Current period cash flow changes

143.09%9.88M

-496.74%-19.45M

-108.36%-83.51M

185.45%120.36M

-273.36%-22.92M

154.52%4.90M

---40.08M

--42.16M

--13.22M

---8.99M

Ending cash balance

218.17%39.78M

-15.59%29.90M

61.68%49.35M

88.18%132.87M

-56.04%12.50M

132.78%35.42M

--30.52M

--70.61M

--28.44M

--15.22M

Free cash flow

-32.20%-18.14M

-106.76%-22.71M

-44.00%-16.13M

-90.00%-14.72M

-85.13%-13.72M

-91.14%-10.98M

---11.20M

---7.75M

---7.41M

---5.75M

Currency unit

USD

Audit opinions

KeyAI

